NGN Capital

NGN Capital

$30,000,000 Venture capital (Series C)
citybizlist

citybizlist : Exosome Diagnostics Raises $30M Series C

$690,000,000
Geektime

Valtech Cardio acquired by Edwards Lifesciences for $1 billion

Strategy Funding
$60,000,000 Venture capital (Series B)
businesswire , FinSMEs , Xconomy

Exosome Diagnostics Completes $60 Million Series B Financing